This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest
Using Bioequivalence and Particle Size Distribution to Develop OINDPs
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Drug Delivery Innovations
Reusable systems and recyclable packaging aid pharma sustainability
Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Sustainability, Innovation & Insights, Drug Delivery Innovations
Case Study – Aptar Pharma’s Metering Valve in pMDIs
Case Studies, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
Confirming bioequivalence for a generic tiotropium dry powder inhalers
Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Product Solutions